K150725 is an FDA 510(k) clearance for the Visaris Avanse. Classified as System, X-ray, Stationary (product code KPR), Class II - Special Controls.
Submitted by Visaris D.O.O. Belgrade (Zemun, RS). The FDA issued a Cleared decision on June 8, 2015 after a review of 80 days - a notably fast clearance cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Visaris D.O.O. Belgrade devices